Username Password
S&P 500: 1,342.64 Change: +0.17%
anab
At least 5 active picks are required to calculate a P&P score.
Open
 
Closed
 
All
 
Commentary
BUY: ANADYS PHARMACEUTICALS INC. (ANDS) Rating: 4
Start Price: $5.01
Points: -92.89
Created: 01/17/2009
There is a need for HEP C vaccine/cure. Blind study went well. Will make money and has a patent on drug. You will make money. I purchased this stock for my daughter and it has more than doubled in just a couple of months! Buy now!

1 Comment(s):

Author anab     Date 2010-02-24 21:38:50
Anadys just released the findings of the Phase II Study with positive results better than 70% improvement. I believe that the stock will continue to rise again. There is no drug currently effective for Hep C. So, if they are the first to create an effective treatment there will be a global demand for it.
Want to comment on this post? Sign up now. It's FREE!
Already registered? Log In.

register
Sponsored Links

Free Options Trader Guide